Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

Микроглия при нейродегенеративных заболеваниях: механизмы и потенциальные терапевтические мишени
Shengdi Chen, Chao Gao, Yuyan Tan, Jingwen Jiang
2023-09-21

microglia activationmicroglial phagocytosisneurodegenerative diseasesneuroinflammationsingle-cell technologies
Microglia activation is observed in various neurodegenerative diseases. Recent advances in single-cell technologies have revealed that these reactive microglia were with high spatial and temporal heterogeneity. Some identified microglia in specific states correlate with pathological hallmarks and are associated with specific functions. Microglia both exert protective function by phagocytosing and clearing pathological protein aggregates and play detrimental roles due to excessive uptake of protein aggregates, which would lead to microglial phagocytic ability impairment, neuroinflammation, and eventually neurodegeneration. In addition, peripheral immune cells infiltration shapes microglia into a pro-inflammatory phenotype and accelerates disease progression. Microglia also act as a mobile vehicle to propagate protein aggregates. Extracellular vesicles released from microglia and autophagy impairment in microglia all contribute to pathological progression and neurodegeneration. Thus, enhancing microglial phagocytosis, reducing microglial-mediated neuroinflammation, inhibiting microglial exosome synthesis and secretion, and promoting microglial conversion into a protective phenotype are considered to be promising strategies for the therapy of neurodegenerative diseases. Here we comprehensively review the biology of microglia and the roles of microglia in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies and Huntington's disease. We also summarize the possible microglia-targeted interventions and treatments against neurodegenerative diseases with preclinical and clinical evidence in cell experiments, animal studies, and clinical trials.
1
Infiltrating peripheral immune cells drive microglia toward a pro-inflammatory phenotype, while microglial extracellular vesicles and aggregate transport may accelerate pathological spread.
2
Microglia can protect the nervous system by phagocytosing pathological protein aggregates, but excessive aggregate uptake impairs phagocytosis and promotes neuroinflammation and neurodegeneration.
3
Microglial autophagy impairment contributes to disease progression and neurodegeneration across multiple neurodegenerative disorders.
4
Promising therapeutic strategies include enhancing microglial phagocytosis, reducing neuroinflammation, inhibiting microglial exosome release, and promoting protective microglial states, supported by preclinical and clinical evidence.
5
Single-cell technologies reveal substantial spatial and temporal heterogeneity among reactive microglia in neurodegenerative diseases.

Microglia in neurodegenerative diseases

The mechanisms, functional roles, and therapeutic targeting of microglia, including their activation states, phagocytosis, neuroinflammation, protein-aggregate propagation, extracellular-vesicle secretion, and autophagy

Publication Details
Publication Date
2023-09-21
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Shengdi Chen
Chao Gao
Yuyan Tan
Jingwen Jiang
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%